Techstars Invests $120,000 in DLT Payments to Accelerate Business Adoption of Stablecoins and CBDCs
Manila is Set to Welcome the World to Inaugural Philippine Blockchain Week
Reach Healthcare Debuts ‘Beyond the Ordinary’ Immersive Technology Experience at HLTH 2022
Reach Healthcare will debut a three-part exhibition at HLTH 2022 entitled "Beyond the Ordinary." It will showcase three multi-sensory immersive solutions for transforming health and well-being care and take attendees on a three-part experiential journey that explores new modalities for addressing: workforce wellness and clinician burnout; improving maternal-infant health outcomes; and boosting post-operative and transitional recovery, rehabilitation and chronic healthcare management.
Reach Healthcare experiences will be centrally located in the Bassano Rooms (#2602, 2603 and 2604) during HLTH 2022, which runs Nov 13 through 16 at the Venetian Expo and Convention Center in Las Vegas NV.
"What if we focused more on sensory elements in health centers, birth centers, diagnostic centers, nursing homes, rehabilitation centers…even hospital-at-home and retail health?" Reach's President, Fran Ayalasomayajula, asks. The Reach sensory solutions go beyond tossing a plant in a corner or drowning out spaces with white noise.
"For centuries research has shown the power of sensory stimulation to heal, revive, and restore," Reach's President, Fran Ayalasomayajula, points out. At HLTH, Reach will present a walking gallery experience infused with elements that stimulate the senses, through the application of transformational and immersive sound and music, visual effects and imagery, textures, smells and tactile interaction.
This first-time offering at HLTH will showcase ways technology can be used to harness positive, calming, healing, and restorative experiences. It will serve as a departure from traditional approaches.
"HLTH is pleased to have Reach Healthcare host their breakthrough immersive therapeutic approach to health and wellbeing at this year's event. This is an important area of focus for HLTH and aligns perfectly with our recently launched brand - WELL by HLTH," said Rich Scarfo, President of HLTH.
Reach Healthcare's mission is to provide a platform that delivers groundbreaking solutions to improve and transform healthcare delivery and outcomes for providers and patients, as well as to offer cost-effective solutions for payers.
THE SCIENCE OF HEALING and WELLNESS: BENEFITS OF MULTISENSORY EXPERIENCES
Reach Healthcare's "Beyond the Ordinary" experiences at HLTH are built on three relevant scientific findings:
- Healthcare Settings Matter. In a 2020 Clinical Empathy study that Reach commissioned with Ipsos, a key finding was that environments matter. Patients seek supportive and familiar environments, and they also place a high value on milestones and memories associated with their environments.
Healthcare Settings directly affect the patient's overall health and well-being, since they also impact relationships, including those of care teams and healthcare consumers. Reach Healthcare solutions enable care facilities, especially hospitals and healthcare providers, to deliver a less stressful experience and minimize the upset and friction between the patient with their providers.
- Sounds and Music Matter. Additional research by Reach revealed that listening to certain sounds and music can reduce anxiety and pain, blood pressure and heart rate, improve sleep quality, mood, mental alertness and memory -- and shorten the length of hospital stays. The layering of digital multimedia and cinematography also delivers similar positive health outcomes.
- Sounds are not limited to the patient journey - but also extend to the provider. The Aesthetic Surgery Journal reported that researchers from the University of Texas Medical Branch at Galveston found that plastic surgeons closed incisions better and faster when done -- while listening to their preferred music.
OTHER COLLABORATIONS
"Beyond the Ordinary" presented by REACH comes to life with the engagement of Reach's technology partners, including HARMAN Digital Transformation Solutions (DTS). REACH's Happy Mama, a maternity app and decision support tool for maternal health professionals, is powered by the HARMAN Remote Care Platform (RCP). Happy Mama will be on display as part of the activation
HARMAN International is a wholly-owned subsidiary of Samsung Electronics Co., Ltd. that is focused on connected technologies for automotive, consumer and enterprise markets.
This collaboration with visual effects powered by Samsung Digital Display Division joins others within the Reach orbit. They include: Birth & Life Photography and MovingArt by Louis Schwartzberg, as seen on Oprah (OWN), Netflix, and Reach Live.
Other contributors to the "Beyond the Ordinary" presented by Reach include OddBall, HealthTunes, Spatial Inc., and Visual Health Solutions.
Reach Healthcare's "Beyond the Ordinary Experience" at HLTH 2022 "takes the attendee on a holistic therapeutic journey through the art and science of healing and wellness -- with the help of immersive multisensory technologies that deliver solutions from a 'people-first' perspective to transform everyday lives," concludes Reach's President, Fran Ayalasomayajula.
ABOUT HLTH 2022:
HLTH (pronounced "health") is the leading platform bringing together the entire health ecosystem, focused on health innovation and transformation. From unparalleled events with industry-leading speakers to inspirational digital content and mission-driven initiatives, HLTH creates a unique marketplace for the health community leading the dialogue and development of a better health ecosystem. Our mission is to gather the health community in curated, purposeful engagements that accelerate healthcare innovation.
Event Registration: https://www.hlth.com/2022event
Media - Special Exhibition Tours: https://www.hlth.com/2022event/media
#hlth2022
ABOUT REACH
REACH is a 501c3 global innovative social impact organization whose mission is to improve and transform healthcare delivery and outcomes for providers and patients, as well as to offer cost-effective solutions for payers.
Maternal mortality and morbidity prevention is a top priority area for the organization. Reach is the founder of the National Save Moms Campaign (http://savemoms.us), Save Moms Global (http://savemoms.global), Maternal Application of Technology for Community Health (MATCH) Coalition (http://matchcoalition.us), and Happy Mama (http://happymama.global).
Reach, established in 2016, is focused on pragmatically improving large-scale and sustainable health programs for enhanced healthcare equity, access, and delivery based on its four pillars: (1) Research to identify where change is needed that could result in actionable outcomes; (2) Education; (3) Thought Leadership and (4) Innovative Immersive Special Interest Therapeutic Platforms, including Happy Mama, focused on maternal health for mothers as well as clinicians; Workforce Wellness to tackle clinician burnout; and IB Healthy Wellness and Remote Care digital therapeutics for rehab, chronic disease management, healthy aging, and more.
Reach welcomes new partnerships, sponsorships, and grassroots affiliates as it works to drive massive impact for better and more equitable healthcare outcomes.
Contact Information:
Matt Walker
Community Outreach Lead
[email protected]
619-800-6443
Press Release Service by Newswire.com
Original Source: Reach Healthcare Debuts 'Beyond the Ordinary' Immersive Technology Experience at HLTH 2022
The GastroIntestinal Research Foundation Launches New Multi-Million Dollar Funding Initiative Aimed at Curing Cancers...
NI Medical Joins Innovators’ Network at American Heart Association Center for Health Technology &...
TEL AVIV, Israel - November 3, 2022 - (Newswire.com)
NI Medical, the inventors of NICaS, the non-invasive hemodynamic monitoring tool, has joined the American Heart Association Center for Health Technology & Innovation's (the Center) Innovators' Network. The Center is focused on building and fostering health technology relationships to develop innovative and scalable solutions.
The Innovators' Network is a healthcare-focused technology consortium that connects entrepreneurs, providers, researchers and payers. Innovators' Network members also have access to the Association's digital guidelines, recommendations, and best-in-class science as they develop digital healthcare technologies. Members collaborate with the Center in different ways, including the building of models for clinical outcome studies, lowering the significant cost of developing those studies independently, helping connect the science to technology, and providing evidence that a digital platform improves healthcare outcomes - a key concern for providers and payers.
"The Center aims to advance the rapid, efficient, and effective development of healthcare technology," said Robert A. Harrington, M.D., FAHA, past president of the American Heart Association (2019-2020), volunteer chair of the American Heart Association's Health Tech Advisory Group for the Center and Arthur L. Bloomfield professor and chair department of medicine, Stanford University. "Joining the Innovators' Network gives members the opportunity to leverage the consortium and work toward broadening and deepening their engagement in this arena."
"Excited to become a part of this exceptional network and join forces to deliver our unique solution for heart failure and hypertension patients management," says Eyal Karev, CEO of NI Medical.
About NI Medical
NI Medical joins the Innovators' Network, bringing with them NICaS, a non-invasive, cost-effective and highly validated hemodynamic management solution.
NICaS is the only whole-body bioimpedance tool that has extensive clinical validation and accuracy capabilities equal to the gold standard (Thermodilution) with extremely high reproducibility. The solution's greatness lies in its ability to provide the cause for the patient's hemodynamic instability - and not only the symptom.
NI Medical presents significant expertise in bioimpedance technology globally. Having developed NICaS, the only whole-body noninvasive hemodynamic management solution, the company has been active globally and in the U.S. market for several years. The solution allows for improved personalized patient therapy, mainly in heart failure and hypertension disease management, as well as other chronic conditions. The solution is highly validated from technology, clinical and commercial perspectives.
MEDIA CONTACT:
Jenny Chernikh
[email protected]
Contact Information:
Jenny Chernikh
Marketing Manager
[email protected]
+9720503032998
Press Release Service by Newswire.com
Original Source: NI Medical Joins Innovators' Network at American Heart Association Center for Health Technology & Innovation
Imagene Named ‘Oncology Innovation of the Year’ at 2022 BioTech Breakthrough Awards
TEL AVIV, Israel - November 3, 2022 - (Newswire.com)
Imagene, an emerging leader in the field of AI-based precision oncology, today announced it has been selected as "Oncology Innovation of the Year" in the second annual BioTech Breakthrough Awards program conducted by BioTech Breakthrough, a leading independent market intelligence organization that evaluates and recognizes standout life sciences and biotechnology companies, products and services around the globe.
The mission of the annual BioTech Breakthrough Awards program is to conduct the industry's most comprehensive analysis and evaluation of the top companies, solutions and products in the life sciences and biotechnology industry today. This year's program attracted more than 1,350 nominations from over 12 different countries throughout the world. Imagene's AI-based Biomarker Detection was chosen as a breakthrough innovation in the field of Medical Technology.
Imagene is a pioneer startup in the Digital Genomics space. Using computer vision algorithms, the company can detect in real-time cancerous genomic alterations directly from the biopsy slide (H&E) scanned image. The idea behind Imagene's innovative development aligns with the notion that actionable (driver) genomic alterations will have a morphological effect on the tissue in a resolution that is impossible for the human eye to detect, but AI and deep learning models can.
"We are honored to be recognized among these great Life Science and BioTech innovators as we continue to advance precision oncology in the fight against cancer," said Dean Bitan, co-founder and CEO at Imagene. "The cancer diagnosis process has evolved to include crucial genomic information; however, long turnaround time, tissue, and cost make its availability limited. Identifying gene alterations is key for improving patient care and guiding targeted therapeutic decisions; physicians should be able to make optimal treatment decisions in a timely and accurate manner. The availability of rapid molecular analysis can sometimes be the difference between life and death."
"Based on the NCCN guidelines, the identification of patient-specific actionable genomic alterations serves as the basis foundation of precision oncology and is utilized routinely for optimal and personalized treatment decisions that drive higher response and mortality rates. The need to use biological specimens and the extended time needed for the analysis and interpretation, as well as inadequate tissue biopsies result in patients not getting life-saving treatment quickly enough," said Bryan Vaughn, Managing Director of BioTech Breakthrough Awards. "Imagene's innovative solution opens the path to fast and accurate cancer diagnosis, demonstrating the huge advancement that AI-based genomic testing can offer to cancer patients' care. All our deep congratulations on winning 'Oncology Innovation of the Year!'"
Imagene has developed 28 different models for actionable alterations across eight cancer types, including Lung, Colorectal, Bladder, Breast, Ovary, Hematology, Thyroid, and brain cancer. The detection accuracy level aligns with the current gold-standard methodologies showing an average sensitivity that is superior to the standard of care. Imagene real-time image-based biomarker detection takes about two minutes, it reduces cost and time significantly with high scalability and seamless integration with routine workflows.
About Imagene
Imagene is a precision oncology diagnosis company with the mission to assist cancer patients in receiving the optimal treatment medicine can offer by leveraging AI to detect, in real-time, a broad range of cancerous biomarkers and clinical insights using only digitized biopsy images. Its multidisciplinary team is composed of a diverse group of experts from the fields of science, medicine, and deep learning. Imagene collaborates with top-tier medical centers and pharmaceutical companies worldwide, striving for fast and accurate cancer diagnosis, profiling patients for clinical trials, and accelerating the drug development process. For more information, visit Imagene-AI.com.
About BioTech Breakthrough
Part of Tech Breakthrough, a leading market intelligence and recognition platform for global technology innovation and leadership, the BioTech Breakthrough Awards program is devoted to honoring excellence in life science and biotechnology solutions, services, and companies. The BioTech Breakthrough Awards provide public recognition for the achievements of biotechnology companies and products in categories including BioPharma, Genomics, Therapeutics, Food Science and BioAgriculture, and more. For more information, visit BioTechBreakthroughawards.com.
Contact Information:
Avital Rabani
Head of Marketing
[email protected]
Press Release Service by Newswire.com
Original Source: Imagene Named 'Oncology Innovation of the Year' at 2022 BioTech Breakthrough Awards
Negative Operating Margins Drive Health Systems to Expand Outsourcing – Black Book 2022 Research...
sam® Education for Medical Students and Providers Expands to Massachusetts
Clinical Research by Salem Anaesthesia Pain Clinic, Surrey, Canada, Shows That Clonidine is Better...
